Golimumab, Guselkumab or both in UC
Neuroimmune modulation through vagus nerve stimulation in CD
Vedolizumab in children with IBD
Ritlecitinib and Brepocitinib in moderate-severe UC
Upadacitinib maintenance in moderate-severe UC
Upadacitinib in Crohn’s disease induction and maintenance
Allopurinol-thiopurine versus standard thiopurine in patients with IBD
Tofacitinib in acute severe ulcerative colitis
Diverting ileostomy closure after pouch construction
Infliximab or azathioprine withdrawal in CD